Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.
Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; no changes to the study content or structure were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check13 days agoChange DetectedThe change is a minor revision log update from v3.2.0 to v3.3.1; no modifications to core study details, eligibility criteria, or outcome measures are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check20 days agoChange DetectedThe page no longer displays the administrative notice about government funding and NIH operating status; core study information such as objectives, eligibility, and locations remains unchanged.SummaryDifference0.4%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedNo significant changes detected in core study information (eligibility criteria, locations, primary/secondary outcomes, or overall study description). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check63 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
- Check70 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.